Skip to main
UHS
UHS logo

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 12 analyst ratings
Hold
Strong Buy 17%
Buy 25%
Hold 50%
Sell 8%
Strong Sell 0%

Bulls say

Universal Health Services Inc. has demonstrated substantial improvement in its financial metrics, with the Acute Care Hospital Services segment achieving a significant 190 basis points expansion in the adjusted EBITDA margin, now at 15.8%. Additionally, the Behavioral Health Services segment exhibited a robust revenue growth of 9.3%, complemented by signs of increasing patient activity due to a 1.3% year-over-year growth in adjusted patient days. Furthermore, anticipated programs pending CMS approval are expected to generate an estimated benefit of $75-80 million, while the overall outlook for 2026 remains favorable with strong pricing power, suggesting potential revenue growth that outpaces costs.

Bears say

The financial outlook for Universal Health Services Inc. remains negative due to anticipated volume and margin headwinds that are expected to result in earnings approximately 5% below current estimates, alongside a projected enterprise multiple consistent with trough levels seen in 2024. Additionally, the company has adjusted its long-term growth outlook downward for behavioral health volumes to a range of 2-3%, with a further forecast indicating a significant decline in DPP contributions expected to impact EBITDA by $420-470 million from 2028 to 2032. The tightening supply of clinical labor poses an additional risk, which could adversely affect productivity and margins, especially in urban settings where competition for employment opportunities is heightened.

UHS has been analyzed by 12 analysts, with a consensus rating of Hold. 17% of analysts recommend a Strong Buy, 25% recommend Buy, 50% suggest Holding, 8% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Hold based on their latest research and market trends.

According to 12 analysts, UHS has a Hold consensus rating as of Dec 5, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $233.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $233.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.